[Today's headlines]

The Ministry of Housing and Construction issued a plan to promote the upgrading of construction and municipal infrastructure equipment

The Zhitong Finance App learned that recently, the Ministry of Housing and Construction issued the “Implementation Plan for Promoting the Renewal of Construction and Municipal Infrastructure Equipment”. The “Implementation Plan” clarifies supporting policies such as investment within the central budget, central financial subsidies, tax incentives, and interest rate rebates, and emphasizes implementing actions to upgrade standards, speeding up the upgrading and elimination of old and substandard equipment such as high energy consumption in the construction and municipal infrastructure sector, and strengthening the guarantee of factors such as land use and energy use for technological transformation projects of relevant enterprises. It involves the Hong Kong stock construction machinery sector.

[General outlook]

COMEX's June gold futures report reached a record closing high of $2351.0 per ounce

Overnight, the US stock Dow fell 11.24 points, or 0.03%, to 38892.80 points; the NASDAQ rose 5.44 points, or 0.03%, to 16253.96 points; and the S&P 500 fell 1.95 points, or 0.04%, to 5202.39 points. Tesla (TSLA.US) rose 4.9%.

The Nasdaq Golden Dragon China Index initially closed up 0.1%, popular Chinese securities rose 4.7%, Canan Technology rose 2.3%, and Station B rose 1.9%. The Hong Kong stock ADR index rose. On a proportional basis, it closed at 16,824 points, up 99.27 points, or 0.69%, from the Hong Kong closing price.

COMEX's June gold futures rose 0.24% to $2351.0 per ounce, another record closing high. International Copper closed up 1.29% at night, Shanghai Copper up 1.31%, Shanghai Aluminum up 0.30%, Shanghai Zinc up 0.90%, Shanghai Lead up 0.12%, Shanghai Nickel up 0.96%, and Shanghai Tin up 2.12%. Alumina closed up 0.36% at night. Stainless steel closed up 0.73% at night.

[Hot preview]

Ministry of Finance: The fourth meeting of the two working groups between China and the US will be held in mid-April

Vice Treasury Secretary Liao Min briefed the media on US Treasury Secretary Yellen's visit to China and answered questions about next steps. In accordance with the instructions of the leaders of the two sides, the working levels of the two sides will continue to push forward the implementation of the above agreement under the Economic and Financial Working Group. The fourth meetings of the two working groups are scheduled to be held separately during the World Bank/International Monetary Fund spring meeting in Washington, USA, in mid-April.

“Interchange” agreement released

According to the Shanghai Securities News, the reporter learned on April 8 that in order to promote the development of the “swap” business and meet participants' legal text requirements, the China Interbank Market Dealers Association and Hong Kong Exchanges and Settlement Limited formulated the “Mainland and Hong Kong Interest Rate Exchange Market Connectivity Cooperation and Liquidation Derivatives Agreement”, which was officially released a few days ago. The “swap” business innovates the central counterparty interconnection mechanism. After domestic and foreign investors reach a transaction at the China Foreign Exchange Trading Center, two central counterparties, Interbank Market Clearing House Co., Ltd. and Hong Kong OTC Clearing Co., Ltd. jointly provide centralized clearing services for interest rate swaps.

Toyota may cooperate with Huawei to create smart driving solutions

Tencent News reported on April 7 that Toyota's intelligent driving solution for global models will adopt the “Toyota+Huawei+Momenta” tripartite joint solution model. Autonomous driving companies Momenta and Huawei each provide software and hardware solutions, and the three parties cooperate and integrate deeply.

Ministry of Education: Higher vocational colleges will add 6068 new specialty points to enroll students from 2024

The Ministry of Education announced today the results of the 2024 Higher Vocational Education Specialist Program Registration. A total of 66,870 majors are to be enrolled in 2024. Compared with 2023, 6068 professional points were added, and 5052 professional points were abolished. In recent years, the Ministry of Education has continuously stepped up efforts to adjust and optimize the settings of higher vocational education majors to guide and support the establishment of higher vocational education majors to serve the country's major strategies, key regional industries and characteristic industries, and the scarce needs of people's livelihood. According to information, the current higher vocational education specialist program registration work has made major adjustments and optimizations to the distribution of majors. This is the largest year since the publication of the new “Vocational Education Professional Catalogue” in 2021. It involves the education sector of the Hong Kong stock paper industry.

China's Jinmao (00817) is discussing refinancing with the bank on a HK$4 billion loan? People familiar with the matter: The news is true, and negotiations are ongoing with the syndicate to renew the loan

In response to market news, China's Jin Mao is currently discussing refinancing matters with the bank on a HK$4 billion loan. In response to Blue Whale News, a person close to China's Jinmao said, “This news is true, and negotiations are under way with the syndicate to renew the loan.” According to reports, the HK$4 billion loan will expire in July. In addition, the source also revealed that at present, the company has prepared sufficient funds to repay the 250 million US dollar bonds due on June 21.

In April, imported online game versions were issued, and a total of 14 games owned by companies such as Tencent (00700) were approved

The Zhitong Finance App learned that on April 8, the State Press and Publication Administration released approval information for online games imported in April. A total of 14 games were approved, including “Mega Man 11” by Tencent (00700) and “Diversive Million King Arthur: Ring” by Perfect World (002624.SZ).

Chuangsheng Group-B (06628) announced the latest business progress in collaborating with Agilent to develop CLDN18.2 companion diagnostic reagents to support global phase III clinical trials of Osemitamab (TST001)

Zhitong Finance App News, Chuangsheng Group-B (06628) issued an announcement to cooperate with Agilent Technologies to develop Claudin18.2 (CLDN 18.2) as a diagnostic reagent to support Osemitamab (TST001) combined with navulimab and chemotherapy as first-line treatment of locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma expressed by CLDN18.2 as a first-line treatment for patients with locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma expressed by CLDN18.2.

Jitu Express - W (01519) achieved a year-on-year increase of 48.5% in package volume of 5,032 billion pieces in the first quarter

The Hong Kong Stock Exchange of Jitu Express released its operating data report for the first quarter of 2024. The Group achieved a volume of 5,032 billion packages during the period, an increase of 48.5% over the previous year, with an average daily package volume of 55.3 million. Among them, the number of packages reached 3,942 million in China, an increase of 46.1% over the previous year, with an average daily package volume of 43.3 million.

[Individual stocks are a bit clear]

Kingsley Biotech (01548): Legendary Biotech announced that the US FDA approved CARVYKTI for second-line treatment of patients with recurrent or refractory multiple myeloma

Zhitong Financial App News, Kingsley Biotech (01548) issued an announcement. Legend Biotech Co., Ltd. (Legend Biotech, a non-wholly-owned subsidiary of the company, and its shares are listed on the US NASDAQ Global Select Market in the form of American Depositary Shares) has submitted Form 6-K to the US Securities Regulatory Commission on April 5, 2024, and announced that the US Food and Drug Administration (US FDA) has approved CARVYKTI (Sidakiorense, cilta-cel) for the treatment of recurrent or refractory multiple myeloma patients. Has received first-line treatment (including proteasome inhibitors and immunomodulators) and is resistant to lenalidomide.